Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro
- PMID: 24700253
- DOI: 10.3892/or.2014.3123
Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro
Abstract
The Notch signaling pathway has been reported to play crucial roles in inhibiting hepatocyte differentiation and allowing formation of intrahepatic bile ducts. However, little is known about its significance in intrahepatic cholangiocarcinoma (ICC). The aim of the present study was to investigate the effects of Notch1 expression in ICC tissues and cells. The expression of Notch1 was examined in paraffin-embedded sections of ICC (n=44) by immunohistochemistry. Notch1 was knocked down by RNA interference (RNAi) in cultured ICC cells (RBE and HCCC-9810). The proliferation, invasiveness and sensitivity to 5-fluorouracil (5-FU) were detected by Cell Counting Kit-8 (CCK-8), colony formation assays, Transwell assays and flow cytometry, respectively. The expression levels of several multidrug resistance (MDR)-related genes, MDR1-P-glycoprotein (ABCB‑1), breast cancer resistance protein (ABCG‑2) and the multidrug resistance protein isoform 1 (MRP‑1), were examined by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting. Notch1 was overexpressed in cell membranes and cytoplasm of ICC compared with the adjacent liver tissue (35/44, 79.5%) and this was more common in cases with tumor size≥5 cm (p=0.021) and HBs-Ag positive (p=0.018). By silencing Notch1, the proliferation and invasiveness of ICC cells were inhibited and the inhibition rate of 5-FU was markedly increased. In addition, IC50 values of 5-FU in RBE cells were decreased from 148.74±0.72 to 5.37±0.28 µg/ml and the corresponding values for HCCC-9810 cells were 326.92±0.87 to 42.60±0.35 µg/ml, respectively. Furthermore, Notch1 silencing clearly increased the percentage of apoptotic cells treated by 5-FU compared with the control. Notch1 knockdown led to diminished expression levels of ABCB‑1 and MRP‑1. Therefore, Notch may play important roles in the development of ICC. Silencing Notch1 can inhibit the proliferation and invasiveness of ICC cells and increase their sensitivity to 5-FU in vitro.
Similar articles
-
The PKHD1 gene inhibits tumor proliferation and invasion in intrahepatic cholangiocarcinoma by activating the Notch pathway.Int J Med Sci. 2024 Oct 14;21(14):2655-2663. doi: 10.7150/ijms.95964. eCollection 2024. Int J Med Sci. 2024. PMID: 39512694 Free PMC article.
-
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z. Chin J Cancer. 2016. PMID: 27469137 Free PMC article.
-
Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.J Transl Med. 2017 Nov 25;15(1):238. doi: 10.1186/s12967-017-1342-1. J Transl Med. 2017. PMID: 29178939 Free PMC article.
-
Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.J Hepatobiliary Pancreat Surg. 2003;10(4):265-81. doi: 10.1007/s00534-002-0729-3. J Hepatobiliary Pancreat Surg. 2003. PMID: 14598145 Review.
-
Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.J Surg Res. 2015 Oct;198(2):434-40. doi: 10.1016/j.jss.2015.03.029. Epub 2015 Mar 19. J Surg Res. 2015. PMID: 25890434 Review.
Cited by
-
Targeting the Ajuba/Notch axis increases the sensitivity of colon cancer cells to 5-fluorouracil.Cytojournal. 2024 Nov 16;21:44. doi: 10.25259/Cytojournal_44_2024. eCollection 2024. Cytojournal. 2024. PMID: 39737130 Free PMC article.
-
Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.Cancer Drug Resist. 2021 Jun 19;4(2):424-452. doi: 10.20517/cdr.2020.114. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582031 Free PMC article. Review.
-
The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.Oncotarget. 2016 Jul 19;7(29):46750-46767. doi: 10.18632/oncotarget.8775. Oncotarget. 2016. PMID: 27102149 Free PMC article. Review.
-
NOTCH signalling - a core regulator of bile duct disease?Dis Model Mech. 2023 Sep 1;16(9):dmm050231. doi: 10.1242/dmm.050231. Epub 2023 Aug 22. Dis Model Mech. 2023. PMID: 37605966 Free PMC article. Review.
-
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.Signal Transduct Target Ther. 2024 May 27;9(1):128. doi: 10.1038/s41392-024-01828-x. Signal Transduct Target Ther. 2024. PMID: 38797752 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical